temozolomide has been researched along with Angioblastic Meningioma in 11 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "A prospective Phase II study of temozolomide (TMZ) was conducted in 16 patients with refractory meningioma." | 9.11 | Temozolomide for treatment-resistant recurrent meningioma. ( Chamberlain, MC; Groshen, S; Tsao-Wei, DD, 2004) |
| "Temozolomide (TMZ) is a DNA alkylating agent that appears to have a radiosensitizing effect when used in combination with RT and may be worthwhile in meningioma treatment." | 5.72 | Concomitant Temozolomide plus radiotherapy for high-grade and recurrent meningioma: a retrospective chart review. ( Belanger, K; Damek, D; Lillehei, KO; Ormond, DR; Ung, TH, 2022) |
| "High-grade meningioma is an aggressive type of brain cancer that is often recalcitrant to surgery and radiotherapy, leading to poor overall survival." | 5.62 | Evaluation of a procaspase-3 activator with hydroxyurea or temozolomide against high-grade meningioma in cell culture and canine cancer patients. ( Basuli, F; Berry, MR; Botham, RC; Chen, Z; Daniel, GB; Fan, TM; Hergenrother, PJ; Huang, S; Joslyn, SK; LeBlanc, AK; Rao, J; Riggins, GJ; Rossmeisl, JH; Tonogai, EJ; Zhang, X, 2021) |
| "A prospective Phase II study of temozolomide (TMZ) was conducted in 16 patients with refractory meningioma." | 5.11 | Temozolomide for treatment-resistant recurrent meningioma. ( Chamberlain, MC; Groshen, S; Tsao-Wei, DD, 2004) |
| "Temozolomide (TMZ) is a DNA alkylating agent that appears to have a radiosensitizing effect when used in combination with RT and may be worthwhile in meningioma treatment." | 1.72 | Concomitant Temozolomide plus radiotherapy for high-grade and recurrent meningioma: a retrospective chart review. ( Belanger, K; Damek, D; Lillehei, KO; Ormond, DR; Ung, TH, 2022) |
| "High-grade meningioma is an aggressive type of brain cancer that is often recalcitrant to surgery and radiotherapy, leading to poor overall survival." | 1.62 | Evaluation of a procaspase-3 activator with hydroxyurea or temozolomide against high-grade meningioma in cell culture and canine cancer patients. ( Basuli, F; Berry, MR; Botham, RC; Chen, Z; Daniel, GB; Fan, TM; Hergenrother, PJ; Huang, S; Joslyn, SK; LeBlanc, AK; Rao, J; Riggins, GJ; Rossmeisl, JH; Tonogai, EJ; Zhang, X, 2021) |
| "Meningiomas are usually cured by surgical resection." | 1.35 | Methylation status of MGMT gene promoter in meningiomas. ( Cairncross, G; de Robles, P; Easaw, J; Forsyth, P; Hamilton, M; Kalra, S; Magliocco, T; McIntyre, J; Roldán, G, 2008) |
| "Thus, we describe a malignant meningioma model system that will be useful for investigating the biology of meningiomas and for preclinical assessment of therapeutic agents." | 1.35 | An orthotopic skull base model of malignant meningioma. ( Baia, GS; Dinca, EB; James, CD; Kimura, ET; Lal, A; McDermott, MW; Ozawa, T; VandenBerg, SR, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Belanger, K | 1 |
| Ung, TH | 1 |
| Damek, D | 1 |
| Lillehei, KO | 1 |
| Ormond, DR | 1 |
| Maeda, O | 1 |
| Ohka, F | 1 |
| Maesawa, S | 1 |
| Matsuoka, A | 1 |
| Shimokata, T | 1 |
| Mitsuma, A | 1 |
| Urakawa, H | 1 |
| Nakamura, S | 1 |
| Shimoyama, Y | 1 |
| Nakaguro, M | 1 |
| Wakabayashi, T | 1 |
| Ando, Y | 1 |
| Tonogai, EJ | 1 |
| Huang, S | 1 |
| Botham, RC | 1 |
| Berry, MR | 1 |
| Joslyn, SK | 1 |
| Daniel, GB | 1 |
| Chen, Z | 1 |
| Rao, J | 1 |
| Zhang, X | 1 |
| Basuli, F | 1 |
| Rossmeisl, JH | 1 |
| Riggins, GJ | 1 |
| LeBlanc, AK | 1 |
| Fan, TM | 1 |
| Hergenrother, PJ | 1 |
| Wilisch-Neumann, A | 1 |
| Pachow, D | 1 |
| Wallesch, M | 1 |
| Petermann, A | 1 |
| Böhmer, FD | 1 |
| Kirches, E | 1 |
| Mawrin, C | 1 |
| He, J | 1 |
| Liu, C | 1 |
| Wang, B | 1 |
| Li, N | 1 |
| Zuo, G | 1 |
| Gao, D | 1 |
| Pellerino, A | 1 |
| Soffietti, R | 1 |
| Rudà, R | 1 |
| Sahuc, P | 1 |
| Joubert, C | 1 |
| Nguyen, AT | 1 |
| Fouet, B | 1 |
| Wybrecht, D | 1 |
| Faivre, A | 1 |
| Alla, P | 1 |
| Dagain, A | 1 |
| de Robles, P | 1 |
| McIntyre, J | 1 |
| Kalra, S | 1 |
| Roldán, G | 1 |
| Cairncross, G | 1 |
| Forsyth, P | 1 |
| Magliocco, T | 1 |
| Hamilton, M | 1 |
| Easaw, J | 1 |
| Rieken, S | 1 |
| Habermehl, D | 1 |
| Haberer, T | 1 |
| Jaekel, O | 1 |
| Debus, J | 1 |
| Combs, SE | 1 |
| Chamberlain, MC | 1 |
| Tsao-Wei, DD | 1 |
| Groshen, S | 1 |
| Baia, GS | 1 |
| Dinca, EB | 1 |
| Ozawa, T | 1 |
| Kimura, ET | 1 |
| McDermott, MW | 1 |
| James, CD | 1 |
| VandenBerg, SR | 1 |
| Lal, A | 1 |
1 review available for temozolomide and Angioblastic Meningioma
| Article | Year |
|---|---|
Glioblastoma Secondary to Meningioma: A Case Report and Literature Review.
Topics: Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Glial Fibrillary Acidic Prote | 2017 |
1 trial available for temozolomide and Angioblastic Meningioma
| Article | Year |
|---|---|
Temozolomide for treatment-resistant recurrent meningioma.
Topics: Administration, Oral; Aged; Antineoplastic Agents, Alkylating; Dacarbazine; Dexamethasone; Disease P | 2004 |
9 other studies available for temozolomide and Angioblastic Meningioma
| Article | Year |
|---|---|
Concomitant Temozolomide plus radiotherapy for high-grade and recurrent meningioma: a retrospective chart review.
Topics: Brain Neoplasms; Child; Humans; Meningeal Neoplasms; Meningioma; Neoplasm Recurrence, Local; Retrosp | 2022 |
Solitary fibrous tumor/hemangiopericytoma treated with temozolomide plus bevacizumab: a report of four cases and literature review.
Topics: Antineoplastic Agents, Immunological; Bevacizumab; Drug-Related Side Effects and Adverse Reactions; | 2020 |
Evaluation of a procaspase-3 activator with hydroxyurea or temozolomide against high-grade meningioma in cell culture and canine cancer patients.
Topics: Animals; Apoptosis; Caspase 3; Cell Culture Techniques; Cell Line, Tumor; Dogs; Humans; Hydroxyurea; | 2021 |
Re-evaluation of cytostatic therapies for meningiomas in vitro.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Dacarbazine; DNA Methylation; DNA Modification M | 2014 |
HMGN5 blockade by siRNA enhances apoptosis, suppresses invasion and increases chemosensitivity to temozolomide in meningiomas.
Topics: Aged; Antineoplastic Agents; Apoptosis; Blotting, Western; Dacarbazine; Drug Resistance, Neoplasm; F | 2015 |
Temozolomide for recurrent meningiomas: a case-report with unexpected clinical and radiological response.
Topics: Antineoplastic Agents, Alkylating; Dacarbazine; Humans; Magnetic Resonance Imaging; Male; Meningeal | 2016 |
Methylation status of MGMT gene promoter in meningiomas.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Dacarbazine; DNA Methylation; DNA Modification Methy | 2008 |
Proton and carbon ion radiotherapy for primary brain tumors delivered with active raster scanning at the Heidelberg Ion Therapy Center (HIT): early treatment results and study concepts.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Carbon; Child; Combined Modality Th | 2012 |
An orthotopic skull base model of malignant meningioma.
Topics: Animals; Antineoplastic Agents, Alkylating; Cell Line, Tumor; Dacarbazine; Disease Models, Animal; D | 2008 |